A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists?

CONCLUSION: Cerebrospinal fluid neurofilament light shows promise as a diagnostic test to assist with the often challenging diagnostic dilemma of distinguishing psychiatric disorders from neurodegenerative and neurological disorders. Further studies are warranted to replicate and expand on these findings, including on plasma neurofilament light. PMID: 31220922 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31220922?dopt=Abstract

Source: The Australian and New Zealand Journal of Psychiatry - June 20, 2019 Category: Psychiatry Authors: Eratne D, Loi SM, Walia N, Farrand S, Li QX, Varghese S, Walterfang M, Evans A, Mocellin R, Dhiman K, Gupta V, Malpas CB, Collins S, Masters CL, Velakoulis D Tags: Aust N Z J Psychiatry Source Type: research